Press Releases

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023

November 1, 2023 at 7:00 AM EDT

PRINCETON, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November.

  • UBS Biopharma Conference in Miami, FL on Thursday, November 9, 2023, at 1:00 p.m. E.T.
  • Stifel 2023 Healthcare Conference in New York, NY on Wednesday, November 15, 2023, at 8:00 a.m. E.T.

A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at, and follow on Twitter and LinkedIn.


Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
(609) 662-3809

Amicus Therapeutics
Diana Moore
Head of Global Corporate Communications
(609) 662-5079